Phase 2 trial shows 83% of adults treated with survodutide achieve significant improvement in MASH
top of page
Browse by category
Search
Up to 83.0% of adults treated with survodutide (Boehringer Ingelheim and Zealand Pharma) achieved a statistically significant improvement...
NICE approves endoscopic sleeve gastroplasty for weight loss management
The UK’s National Institute for Health and Care Excellence (NICE) has approved the use of endoscopic sleeve gastroplasty (ESG) for weight...
Intraoperative leak tests correlated with increase in staple line leakage but a lower rate of postoperative bleeding
Intraoperative leak test (IOLT) is correlated with an increase in staple line leakage (SLL) when included as a part of a sleeve...
First procedures utilising ReShape’s next-generation Lap-Band 2.0 FLEX
ReShape Lifesciences has announced that the first procedures utilising the company’s next generation, enhanced Lap-Band 2.0 FLEX, have...
Journal Watch 22/2/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Interdisciplinary therapy programme reduces inflammation and cardiometabolic risk in adolescents with obesity
After a one-year interdisciplinary therapy programme that included clinical, nutritional, psychological and exercise counselling, a group...
Tranexamic acid results in better LSG outcomes compared to placebo
Tranexamic acid (TXA) demonstrates a robust safety and efficacy profile for its use in patients undergoing laparoscopic sleeve...
Browse by tag
bottom of page